Clinical Trials Browser

INDUSTRY × Pancreatic Neoplasms × anlotinib × Clear all

NCT06767813 2025-09-19

Clinical Study of TQB2868 Injection Combined With Anlotinib Capsule and Chemotherapy in the First-line Treatment of Metastatic Pancreatic Neoplasms

Phase 2 Recruiting

Gastrointestinal

Pancreatic Neoplasms